English Aron R.
CIK 0001770436 Name as filed on the most recent filing
Filed as English Aron R. (44)
100 transaction lines · from 44 filings · filed 2019-04-09 to 2026-04-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Foster L B Co 11 filings
- ISSUER Lifecore Biomedical, Inc. \De\ 4 filings
- ISSUER Culp Inc 10 filings
- ISSUER Anebulo Pharmaceuticals, Inc. 5 filings
- ISSUER Dirtt Environmental Solutions Ltd 8 filings
- ISSUER Strata Skin Sciences, Inc. 1 filings
- ISSUER Armstrong Flooring, Inc. 3 filings
- ISSUER Merrimack Pharmaceuticals Inc 2 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-01 |
Foster L B Co FSTR |
S, Open-market sale | 38,431 disposed | 28.05 | 1,077,885.79 | Form 4, filing 0000921895-26-000906 | |
| 2026-03-31 |
Foster L B Co FSTR |
S, Open-market sale | 1,500 disposed | 28.02 | 42,030.00 | Form 4, filing 0000921895-26-000906 | |
| 2026-03-30 |
Foster L B Co FSTR |
S, Open-market sale | 1,887 disposed | 28.01 | 52,856.95 | Form 4, filing 0000921895-26-000838 | |
| 2026-03-27 |
Foster L B Co FSTR |
S, Open-market sale | 862 disposed | 28.02 | 24,153.24 | Form 4, filing 0000921895-26-000838 | |
| 2026-03-26 |
Foster L B Co FSTR |
S, Open-market sale | 8,968 disposed | 28.02 | 251,290.53 | Form 4, filing 0000921895-26-000838 | |
| 2026-03-25 |
Foster L B Co FSTR |
S, Open-market sale | 2,716 disposed | 28.09 | 76,281.58 | Form 4, filing 0000921895-26-000808 | |
| 2026-03-24 |
Foster L B Co FSTR |
S, Open-market sale | 25,889 disposed | 28.19 | 729,717.71 | Form 4, filing 0000921895-26-000808 | |
| 2026-03-23 |
Foster L B Co FSTR |
S, Open-market sale | 78,414 disposed | 28.51 | 2,235,606.66 | Form 4, filing 0000921895-26-000808 | |
| 2026-03-04 |
Foster L B Co FSTR |
S, Open-market sale | 5,124 disposed | 31.99 | 163,906.51 | Form 4, filing 0000921895-26-000635 | |
| 2025-12-12 |
Foster L B Co FSTR |
S, Open-market sale | 13,512 disposed | 26.79 | 361,925.68 | Form 4, filing 0000921895-25-003329 | |
| 2025-12-11 |
Foster L B Co FSTR |
S, Open-market sale | 34,025 disposed | 26.79 | 911,669.25 | Form 4, filing 0000921895-25-003329 | |
| 2025-12-10 |
Foster L B Co FSTR |
S, Open-market sale | 11,248 disposed | 26.83 | 301,823.21 | Form 4, filing 0000921895-25-003311 | |
| 2025-12-09 |
Foster L B Co FSTR |
S, Open-market sale | 4,800 disposed | 26.93 | 129,240.48 | Form 4, filing 0000921895-25-003311 | |
| 2025-12-08 |
Foster L B Co FSTR |
S, Open-market sale | 9,765 disposed | 27.28 | 266,362.83 | Form 4, filing 0000921895-25-003311 | |
| 2025-12-01 |
Foster L B Co FSTR |
S, Open-market sale | 101 disposed | 26.82 | 2,708.50 | Form 4, filing 0000921895-25-003249 | |
| 2025-11-28 |
Foster L B Co FSTR |
S, Open-market sale | 1,307 disposed | 27.09 | 35,400.75 | Form 4, filing 0000921895-25-003249 | |
| 2025-11-25 |
Foster L B Co FSTR |
S, Open-market sale | 1,725 disposed | 26.94 | 46,467.19 | Form 4, filing 0000921895-25-003202 | |
| 2025-11-24 |
Foster L B Co FSTR |
S, Open-market sale | 27,003 disposed | 26.84 | 724,644.41 | Form 4, filing 0000921895-25-003202 | |
| 2025-11-21 |
Foster L B Co FSTR |
S, Open-market sale | 3,412 disposed | 27.03 | 92,222.27 | Form 4, filing 0000921895-25-003202 | |
| 2025-11-17 |
Foster L B Co FSTR |
S, Open-market sale | 400 disposed | 27.00 | 10,800.00 | Form 4, filing 0000921895-25-003153 | |
| 2025-11-14 |
Foster L B Co FSTR |
S, Open-market sale | 2,247 disposed | 27.00 | 60,669.00 | Form 4, filing 0000921895-25-003153 | |
| 2025-11-13 |
Foster L B Co FSTR |
S, Open-market sale | 1,600 disposed | 27.00 | 43,203.04 | Form 4, filing 0000921895-25-003030 | |
| 2025-11-12 |
Foster L B Co FSTR |
S, Open-market sale | 3,368 disposed | 27.06 | 91,152.56 | Form 4, filing 0000921895-25-003030 | |
| 2025-11-11 |
Foster L B Co FSTR |
S, Open-market sale | 4,813 disposed | 28.17 | 135,605.79 | Form 4, filing 0000921895-25-003030 | |
| 2025-11-11 |
Foster L B Co FSTR |
S, Open-market sale | 2,749 disposed | 27.52 | 75,648.91 | Form 4, filing 0000921895-25-003030 | |
| 2025-05-28 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 150,419 disposed | 7.12 | 1,071,554.87 | Form 4, filing 0000950170-25-078524 | |
| 2025-05-27 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 1,139,504 disposed | 6.50 | 7,411,561.92 | Form 4, filing 0000950170-25-078524 | |
| 2025-05-23 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 96,137 disposed | 6.75 | 649,386.21 | Form 4, filing 0000950170-25-078524 | |
| 2025-05-13 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 12,334 disposed | 7.00 | 86,352.80 | Form 4, filing 0000950170-25-073196 | |
| 2025-05-12 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 45,698 disposed | 7.03 | 321,426.02 | Form 4, filing 0000950170-25-069576 | |
| 2025-05-09 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 700 disposed | 7.00 | 4,900.00 | Form 4, filing 0000950170-25-069576 | |
| 2025-05-08 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 5,098 disposed | 7.00 | 35,693.14 | Form 4, filing 0000950170-25-069576 | |
| 2025-05-07 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 15,847 disposed | 7.01 | 111,098.56 | Form 4, filing 0000950170-25-066222 | |
| 2025-05-06 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 701 disposed | 7.05 | 4,940.09 | Form 4, filing 0000950170-25-066222 | |
| 2025-05-05 |
Lifecore Biomedical, Inc. \De\ LFCR |
S, Open-market sale | 24,543 disposed | 7.08 | 173,830.71 | Form 4, filing 0000950170-25-066222 | |
| 2025-03-19 |
Culp Inc CULP |
P, Open-market purchase | 20,000 acquired | 5.60 | 111,954.00 | Form 4, filing 0000921895-25-000835 | |
| 2025-03-18 |
Culp Inc CULP |
P, Open-market purchase | 104,738 acquired | 5.35 | 560,348.30 | Form 4, filing 0000921895-25-000835 | |
| 2025-03-17 |
Culp Inc CULP |
P, Open-market purchase | 4,220 acquired | 5.17 | 21,814.45 | Form 4, filing 0000921895-25-000797 | |
| 2025-03-14 |
Culp Inc CULP |
P, Open-market purchase | 9,006 acquired | 5.08 | 45,744.18 | Form 4, filing 0000921895-25-000797 | |
| 2025-03-13 |
Culp Inc CULP |
P, Open-market purchase | 9,793 acquired | 5.07 | 49,690.66 | Form 4, filing 0000921895-25-000797 | |
| 2025-03-12 |
Culp Inc CULP |
P, Open-market purchase | 6,077 acquired | 5.05 | 30,697.36 | Form 4, filing 0000921895-25-000751 | |
| 2025-03-11 |
Culp Inc CULP |
P, Open-market purchase | 66,663 acquired | 5.00 | 333,128.34 | Form 4, filing 0000921895-25-000751 | |
| 2025-03-10 |
Culp Inc CULP |
P, Open-market purchase | 13,849 acquired | 4.65 | 64,338.30 | Form 4, filing 0000921895-25-000751 | |
| 2024-12-23 |
Anebulo Pharmaceuticals, Inc. ANEB |
P, Open-market purchase | 10,101,010 acquired | 0.99 | 9,999,999.90 | Form 4, filing 0001493152-24-052101 | |
| 2024-12-20 |
Culp Inc CULP |
P, Open-market purchase | 4,564 acquired | 5.23 | 23,867.89 | Form 4, filing 0000921895-24-003006 | |
| 2024-12-19 |
Culp Inc CULP |
P, Open-market purchase | 7,634 acquired | 5.25 | 40,078.50 | Form 4, filing 0000921895-24-003006 | |
| 2024-12-18 |
Culp Inc CULP |
P, Open-market purchase | 1,246 acquired | 5.25 | 6,540.13 | Form 4, filing 0000921895-24-003006 | |
| 2024-12-11 |
Culp Inc CULP |
P, Open-market purchase | 2,300 acquired | 5.23 | 12,018.42 | Form 4, filing 0000921895-24-002931 | |
| 2024-12-10 |
Culp Inc CULP |
P, Open-market purchase | 11,794 acquired | 5.05 | 59,617.49 | Form 4, filing 0000921895-24-002931 | |
| 2024-12-09 |
Culp Inc CULP |
P, Open-market purchase | 2,787 acquired | 4.96 | 13,814.88 | Form 4, filing 0000921895-24-002931 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. English Aron R., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001770436
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6